CRI Speaks with 2019 AACR-CRI Lloyd J. Old Award Recipient, Dr. Cornelis 'Kees' Melief

April 02, 2019

CRI Speaks with 2019 AACR-CRI Lloyd J. Old Award Recipient, Dr. Cornelis 'Kees' Melief

Cornelis J. M. ‘Kees’ Melief, M.D., Ph.D., received the 2019 AACR-CRI Lloyd J. Old Award in Cancer Immunology presented by the American Association for Cancer Research (AACR) and Cancer Research Institute (CRI) during the 2019 AACR Annual Meeting.

Dr. Melief, a member of the CRI Scientific Advisory Council and CLIP Grant Review Committee, is being honored for his work on the development of effective immunotherapies for virus-induced tumors, including a novel vaccine strategy that uses synthetic long peptides (SLP) to target cancers associated with infection by the human papilloma virus (HPV). Arthur N. Brodsky, Ph D. interviewed Dr. Melief. Please go to the following link for the full text interview.

https://www.cancerresearch.org/blog/april-2019/cornelius-melief-interview-lloyd-j-old-award

Home > Press Releases > CRI Speaks with 2019 AACR-CRI Lloyd J. Old Awar...

© 2019 Aglaia Oncology Funds | Privacy | Sitemap
Aglaia Oncology Funds